Yıldız Dallar Selected Research

DNA (Deoxyribonucleic Acid)

1/2011

A novel pathogenic DNA variation in the OCRL1 gene in Lowe syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yıldız Dallar Research Topics

Disease

1	Hypothyroidism 09/2012
1	Thrombophilia 09/2012
1	Oculocerebrorenal Syndrome (Lowe Syndrome) 01/2011
1	Crohn Disease (Crohn's Disease) 01/2009
1	Inappropriate ADH Syndrome (SIADH) 01/2009
1	Meningitis 01/2009
1	Hyponatremia 01/2009

Drug/Important Bio-Agent (IBA)

1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 09/2012
1	AntigensIBA 09/2012
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2012
1	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2012
1	Plasminogen InactivatorsIBA 09/2012
1	ThrombomodulinIBA 09/2012
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 09/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	SaltsIBA 01/2009